Immunosurveillance and Immunoregulation by γδ T Cells  by Girardi, Michael
PERSPECTIVE
© 2006 The Society for Investigative Dermatology www.jidonline.org 25
The coordinated responses of several 
different lymphoid subsets are critical to 
the protection of the host from various 
outside challenges. Epithelial surfaces, 
including the skin, serve as selective 
barriers where the immune system first 
encounters tissue-damaging radiation, 
toxins, mutagens, and various microor-
ganisms. Studies in mice and humans 
have advanced the understanding of 
the integrated responses of T cells — 
including the major subsets defined by 
their TCR usage, αβ and γδ — and their 
relationship to other lymphoid cells, 
such as natural killer (NK) and natural 
killer T (NKT) cells. Parallel to the mech-
anisms that enable protective immune 
effects, misdirected and/or excessive 
activities of lymphoid cells may result 
in autoimmune or inflammatory disease 
states. Fortunately, cells with a regula-
tory function help to maintain immu-
nologic balance. It is within this context 
that the crucial roles played by γδ T cells 
are increasingly being understood, an 
effort aided in large part by studies with 
mice in which the TCRδ locus has been 
genetically disrupted (that is, TCRδ–/– 
knockout mice) and no γδ T cells are 
present. Studies of skin cancer and con-
tact dermatitis in these and other genet-
ic variants have shed new light on the 
functions of γδ T cells, their relationship 
to other lymphoid cells, and the impli-
cations of such for the understanding 
of immune surveillance in human skin. 
Likewise, studies of murine γδ T cells 
have elucidated their similarities and 
differences relative to the more popu-
lous αβ T cells (Table 1).
For all four TCR loci (α, β, γ, and 
δ), the recombination of variable (V), 
diversity (D; for β and δ chains), and 
junctional (J) region sequence elements 
(Table 2) generates a vast degree of TCR 
diversity (reviewed in Janeway et al., 
2001), similar to the generation of B-cell 
antibody diversity via recombination of 
heavy and light chains. Within the area 
of the V(D)J joins — what is referred to 
as the complementarity-determining 
region 3 (CDR3) — additional vari-
ability may be introduced via random 
nucleotide insertion and/or deletion. 
It is the CDR3 that encodes the hyper-
variable TCR loops of antigen recogni-
tion. Though the basic heterodimeric 
structure of αβ and γδ TCRs is similar, 
there are several key differences in their 
array of genetic elements, the nature of 
their recombination, and their ultimate 
diversity. For example, there are far 
more V elements that may be utilized 
in α and β gene rearrangements; never-
theless, γδ TCRs have a greater potential 
diversity because of their capacity to 
use multiple tandem copies of their D 
elements. A detailed analysis of CDR3 
length (Rock et al., 1994) revealed that 
TCR α- and β-chain distributions are 
highly constrained, doubtless because 
of structural requirements enabling 
binding and recognition of antigenic 
peptide within major histocompat-
ibility complex (MHC) molecules. In 
contrast, TCRδ chains are highly vari-
able in length, resembling antibody 
heavy chain in this manner. This find-
ing is consistent with the understanding 
that γδ TCRs have antigen recognition 
properties fundamentally different from 
those of αβ TCRs and likely bind their 
respective antigens in a fashion similar 
to that of antibodies (that is, indepen-
dent of MHC presentation, and in a 
fashion more dependent on conforma-
tional shape of intact protein or non-
protein compounds) (Table 3).
Tissue Distribution and Major Subsets of 
γδ T Cells
Most T cells express TCRαβ and either of 
the TCR-associated molecules CD4 and 
CD8 on their surface, but a minority (1–
10%) demonstrates a TCRγδ+, predomi-
nantly CD4–CD8– 'double-negative' phe-
notype. In the mouse, a substantial pro-
portion of γδ T cells reside in the intraep-
ithelial lymphocyte (IEL) compartments 
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of skin, intestine, and genitourinary 
tract. Within the fetal thymus, precursors 
for these γδ T cells emerge in successive 
waves, guided to their respective tissues 
by the loss and gain of appropriate che-
mokine receptors. Vγ5Vδ1+ T cells are 
the first to leave the mouse fetal thymus 
and take residence in the suprabasal 
epidermis, forming a dendritic network 
that is unique among T cells but simi-
lar to that of Langerhans cells, the anti-
gen-presenting cells of the epidermis. In 
physiologic states, these Vγ5+ den-
dritic epidermal T cells (DETCs) consti-
tute more than 90% of the epidermal 
T cells, with virtually no TCR diversity 
(Bergstresser et al., 1985). No pheno-
typically equivalent γδ+ IEL population 
has been identified in human epidermis, 
but γδ+ T cells of limited diversity and 
distinct from the peripheral blood γδ T-
cell populations clearly reside within 
the dermis (Holtmeier et al., 2001). 
Characterization of these cells and their 
role in local immune responses awaits 
further investigation.
Several studies have demonstrated that 
the TCR expressed by the IEL population 
directs the association with the particular 
epithelial tissue. For example, develop-
ing DETCs demonstrate a more diverse 
set of γδ TCRs in the neonatal period, and 
these become much more uniform over 
the first few weeks of life (Tigelaar and 
Lewis, 1995). Eventually, in a manner 
analogous to that of Vγ5 DETCs, other γδ 
T-cell subsets of limited TCR diversity 
are restricted to other epithelial tissues 
(for example, Vγ6+ T cells in the genito-
urinary tract, Vγ7+ T cells in the intesti-
nal tract) (Itohara et al., 1989; Asarnow 
et al., 1989). This strongly suggests that 
a set of corresponding self-ligands is 
present in fetal and/or neonatal epithe-
lia. Although no such set of IEL TCR-
specific epithelial ligands has yet been 
definitively identified, several inves-
tigators have suggested that they may 
be expressed within the fetal thymus 
(allowing positive selection), as well as 
within each fetal/neonatal epithelium 
(allowing homing, peripheral selection, 
and expansion), but subsequently only 
on stressed or dysregulated epithelial 
cells (Janeway et al., 1988; Allison and 
Havran, 1991).
This hypothesis would be consistent 
with the paradigm that γδ IELs play a 
large role in protection of epithelial 
barriers via monitoring and appropri-
ate destruction of stressed (that is, dys-
regulated, metabolically compromised, 
and/or transformed) epithelial cells 
(Pardoll, 2001). In the skin, DETCs may 
additionally promote wound healing, 
effectively protecting the barrier from 
microbial invasion and dissemination 
throughout the organism (Jameson et 
al., 2002). Additionally, γδ T cells may 
be important in helping to regulate 
inflammatory responses stimulated by 
αβ T cells, protecting against overly 
exuberant immune responses that might 
otherwise cause excessive tissue dam-
age. Thus, an improved understanding 
of γδ T cells and their relationships to 
the skin has major implications for an 
improved understanding of cutaneous 
malignancy, infection, and inflamma-
tory disease.
In the human fetal thymus, the first 
γδ T cells to emerge use the Vδ1 chain 
(paired with various Vγ chains), and 
these will eventually preferentially 
populate epithelial tissues such as the 
intestine (Hayday et al., 2001). Thus, 
whereas such Vδ1+ T cells constitute 
only a minor proportion of the γδ T 
cells present in human blood, they con-
stitute a much larger proportion of the 
human IELs and have also been found 
to be enriched within various human 
epithelial tumors (for example, lung, 
kidney, and colon carcinomas) and 
lymphomas (Fisch et al., 1997). Vδ1 T 
cells appear to recognize stressed cells 
via presentation of self-lipids by CD1 
and/or expression of stress-induced 
Table 1. Comparison of αβ and γδ T cells in mice
Feature αβ T cells γδ T cells
CD4 and CD8 
phenotype
Major subsetting based on CD4 or 
CD8 expression
Predominantly CD4–CD8– 
(double-negative); murine 
intestinal IELs may be CD8αα+
Antigen type and 
presentation
Peptide antigen in the grooves of 
MHC-I or -II; primary responses 
require antigen-presenting cell
Identifi cation of TCR ligands 
incomplete; β2 microglobulin 
independent; some subsets 
recognize MHC-Ib molecules 
T helper functions Predominantly CD4+; T helper 1 
and 2 cytokine profi les
T helper 1 and 2 cytokine 
profi les
T cytotoxic functions Predominantly CD8+; e.g., perforin/
granzyme production, Fas ligand-
mediated, NKG2D-mediated
Various subsets using the same 
mechanisms
T regulatory functions Various T regulatory subsets 
including CD4+CD25+ cells
Attributable to various subsets, 
including murine Vγ5+ DETCs 
and human Vγ1+ peripheral cells
TCR junctional diversity Relatively vast Relatively limited; especially 
limited for IEL populations
Abbreviations: DETC, dendritic epidermal T cell; IEL, intraepithelial lymphocyte; MHC, major 
histocompatibility complex.
Table 2. TCR V(D)J gene segments of αβ and γδ T cells1
γδ Segments αβ Segments
Mouse Human Mouse Human
Vδ 11 3 Vα 23 41
Dδ 2 3 Jα 61 61
Jδ 2 4
Vβ 31 30
Vγ 7 5 Dβ 2 2
Jγ 4 3 Jβ 14 14
1Total number of genes that are available for recombination for both mouse and human TCRs.
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MHC-Ib molecules. In contrast, Vγ9Vδ2 
T cells (also referred to as Vγ2Vδ2; for 
nomenclature, see Kabelitz and Wesch, 
2003) continually expand and take on 
a memory phenotype during child-
hood, presumably because of recurrent 
exposure to foreign agents, such that 
they eventually constitute approximate-
ly 80% of the γδ T cells of normal adult 
human blood. These cells will recog-
nize, expand, and release cytokines in 
response to non-peptide compounds 
found across a spectrum of microbial 
pathogens as well as within mamma-
lian cells.
The immune system has classically 
been divided into two major arms: the 
more evolutionarily primitive innate 
immune system, where cell recep-
tors and molecules may recognize 
and permit a rapid beneficial response 
to a variety of foreign agents, and the 
adaptive immune system, where B and 
T cells with antigen-specific receptors 
will produce a slower but more spe-
cific and coordinated initial immune 
response while also leading to expan-
sion and a memory phenotype ready 
for subsequent challenges by the same 
antigen. One on hand, γδ T cells may 
be considered a component of the 
adaptive immune system in that they 
rearrange TCR genes to produce junc-
tional diversity and will develop a 
memory phenotype. However, the vari-
ous subsets may also be considered part 
of the innate immune system, where 
a restricted TCR may be used as a pat-
tern recognition receptor. For example, 
according to this paradigm (Holtmeier 
and Kabelitz, 2005), large numbers of 
memory Vγ9Vδ2 T cells will respond 
within hours to common molecules 
produced by microbes, and highly 
restricted intraepithelial Vδ1 T cells 
will respond to stressed epithelial cells 
bearing sentinels of danger. Clearly, the 
complexity of γδ T-cell biology spans 
definitions of both innate and adaptive 
immune responses.
Antimicrobial Immunosurveillance by γδ 
T Cells
A range of studies have demonstrated 
a marked expansion of γδ T cells in the 
blood of systemically infected patients, 
including those with leprosy, tuber-
culosis, malaria, tularemia, salmonel-
losis, brucellosis, ehrlichiosis, or bac-
terial meningitis due to Haemophilus 
influenzae, Neisseria meningitidis, or 
Streptococcus pneumoniae (reviewed 
in Chen and Letvin, 2003). The broad 
recognition of the response may be 
the direct result of Vγ9Vδ2 stimula-
tion by one of two major sets of shared 
non-peptide compounds: isopentenyl 
pyrophosphate and other intermediates 
of the mevalonate pathway; and alkyl-
amines, non-phosphate compounds 
ubiquitously found in plants and bacte-
ria (reviewed in Holtmeier and Kabelitz, 
2005). In fact, the most potent natural 
stimulator of Vγ9Vδ2 T cells appears to 
be (E)-4-hydroxy-3-methylbut-2-enyl 
diphosphate, one of the precursors of 
isopentenyl pyrophosphate synthesis. 
Importantly, phosphoantigens are found 
expressed on many human tumor cells, 
possibly reflecting their state of raised 
metabolic stress, and will stimulate 
secretion of cytotoxic molecules by 
Vγ9Vδ2 cells (Bonneville and Fournie, 
2005). Synthetic aminobisphospho-
nate compounds (for example, the drug 
pamidronate) also stimulate Vγ9Vδ2 
cells, but this is more likely due to their 
stimulation of farnesyl diphosphate 
Table 3. Characteristics of γδ+ T-cell subsets as defi ned by TCR usage
γ/δ Usage1 Subset characteristics2
Murine subsets
Vγ1 Major peripheral recirculating γδ T cells of the blood and lymphatics
Downregulatory function, such as autoimmune myocarditis (see 
also Vγ4)
Subset capable of killing Listeria-infected macrophages via Fas/Fas 
ligand, whereas other Vγ1 subset may be downregulatory
Vγ2 Recognizes non-classical MHC-Ib molecules, for example, T22, T10 
(Shin et al., 2005)
Implicated in protection against lung mycobacteria
Vγ4 Pro-infl ammatory functions, for example, autoimmune myocarditis
Vγ5Vδ11 Vast majority of the IELs of the skin, the prototypic DETCs
First subset of T cells to emerge from the fetal thymus
May lyse stressed/transformed keratinocytes via NKG2D ligands (for 
example, Rae-1)
Downregulatory function for αβ T cell-mediated infl ammation
Vγ6Vδ1 Vast majority of the IELs of the tongue and reproductive tract
Vγ7 Vast majority of the γδ+ IELs of the intestine (with Vδ4/Vδ5)
Generated in the absence of a functional thymus
Human subsets
Vδ1 Large component of the γδ+ IELs of the intestine
Frequently found infi ltrating tumors of epithelial origin
May lyse stressed/transformed epithelial cells via recognition of NKG2D 
ligands (for example, MICA)
Vγ9Vδ21 Major peripheral recirculating γδ T cells of the blood and lymphatics
Recognizes and expands in response to isoprenoids and alkylamines
Has demonstrated cytotoxicity to a variety of cancer cell lines (for 
example, lymphoma, myeloma, prostate, renal)
Kills both intracellular and extracellular Mycobacterium tuberculosis 
organisms (Dieli et al., 2001) 
May also function as professional antigen-presenting cells (Brandes et 
al., 2005)
1Vγ5Vδ1 is also known as Vγ3Vδ1; Vγ9Vδ2 is also known as Vγ2Vδ2 (for further clarification of 
TCRγδ nomenclature, see Kabelitz and Wesch, 2003). 2See Huber et al., 2005; Dalton et al., 2004. 
Abbreviations: DETC, dendritic epidermal T cell; IEL, intraepithelial lymphocyte; MHC, major 
histocompatibility complex; MICA, MHC class I chain-related A.
M Girardi
γδ T cells
28 Journal of Investigative Dermatology (2006), Volume 126
synthetase, which leads to accumula-
tion of isopentenyl pyrophosphate. 
Studies are ongoing to identify potential 
immunostimulatory phosphoantigen 
drugs that might be therapeutic against 
malignancy (Wilhelm et al., 2003; 
Lozupone et al., 2004; Liu et al., 2005) 
and/or infection (Wang et al., 2001).
Human peripheral Vγ9Vδ2 cells, 
after their exposure to foreign infec-
tious agents or dying or metaboli-
cally stressed host cells (for example, 
in tumor states), may enhance other 
immune components as well. Through 
the rapid secretion of chemokines and 
T helper 1 cytokines such as IFN-γ, 
Vγ9Vδ2 cells may stimulate NK, NKT, 
and αβ T-cell functions (Smith and 
Hayday, 2000). Moreover, Brandes 
et al. (2005) recently discovered that 
Vγ9Vδ2 cells can also function as 
professional antigen-presenting cells 
capable of ingesting, processing, and 
presenting peptide antigens to stimu-
late both CD4+ and CD8+ subsets of 
αβ T cells. These findings collectively 
describe a scenario whereby Vγ9Vδ2 
cells may be very early responders to 
states of infection or host cellular dys-
regulation, providing direct cytotoxic 
effects, altering the local cytokine/
chemokine milieu to facilitate other 
lymphoid cells and initiating antigen-
specific αβ T-cell immune responses 
through their capacity to function 
as APCs much like dendritic cells 
(Brandes et al., 2005).
Antitumor Immunosurveillance by γδ 
T Cells
Within human epithelial compart-
ments, γδ T cells, most notably gut Vδ1+ 
T cells, may express surface NKG2D, 
a molecule found on two other major 
subsets of cells with cytotoxic poten-
tial, namely CD8+ αβ T cells and NK 
cells. Engagement of NKG2D by one 
of its several identified ligands, includ-
ing MHC class I chain-related A and B 
(MICA and MICB) in humans (Bauer 
et al., 1999) and retinoic acid early-1 
(Rae-1) in mice (Cerwenka et al., 2000), 
provides a co-stimulatory function and 
targets cellular destruction. These mol-
ecules are upregulated under cellular 
stress and are expressed on a variety of 
tumor cells (Groh et al., 1999), includ-
ing melanoma (Vetter et al., 2002). 
They may act as signals that target host 
cells for destruction by locally resi-
dent or infiltrating γδ T cells as well as 
other NKG2D+ lymphoid cells. When 
the prototypic γδ IELs of mouse skin, 
the Vγ5+ DETCs, are co-cultured with 
a keratinocyte tumor line expressing 
the NKG2D ligand Rae-1, the trans-
formed cells are lysed, and such kill-
ing is dependent on TCR engagement 
(Girardi et al., 2001).
More recently, the relative contribu-
tions of αβ and γδ T cells to cutaneous 
tumor immunosurveillance have been 
systematically studied in mice (Girardi 
et al., 2001; Girardi et al., 2003b; 
Gao et al., 2003; Girardi et al., 2004). 
Intradermal injection of the mutagen 
methylcholanthrene can provoke the 
development of poorly differentiated 
fibrosarcomas and spindle-cell carci-
nomas. This occurs with shorter latency 
in TCRδ–/– mice. Similarly, tumors form 
more readily in γδ-deficient mice after 
injection of squamous-cell carcinoma 
(Girardi et al., 2001) or melanoma 
(Gao et al., 2003) tumor cell lines. In 
addition to the potential of γδ T cells 
to directly lyse transformed cells in an 
NKG2D-dependent fashion, infiltrating 
γδ T cells have also been shown to pro-
duce IFN-γ early in tumor development 
(Gao et al., 2003).
The concept that the different T-cell 
compartments may contribute to tumor 
surveillance in distinct fashions and at 
different stages of tumor growth has been 
further explored in the system of two-
stage chemical carcinogenesis (where 
tumor development may be monitored 
after a single application of the mutagen 
7,12-dimethylbenz[a]anthracene to the 
skin followed by repeated application of 
the tumor-promoting agent D12-O-tetra-
decanoylphorbol-13-acetate) (Hennings 
et al., 1993; Owens et al., 1999). In 
this system, benign papillomas readily 
develop and can progress to squamous-
cell carcinoma. In TCRδ–/– mice, both the 
development of papillomas and the pro-
gression to carcinoma were significantly 
increased (Girardi et al., 2001). This 
result, revealing that γδ T cells not only 
inhibit the early stages of tumor devel-
opment but also limit progression to car-
cinoma, is consistent with the use of two 
or more different antitumor mechanisms 
by γδ T cells.
Further insight was provided by 
studies in TCRβ–/– mice, which lack αβ 
T cells. Under an intense regimen of 
chemical promotion, tumors were sig-
nificantly less likely to progress to car-
cinoma than in normal controls. This 
indicated a paradoxical tumor-promot-
ing effect attributable to αβ T cells, 
an observation made in several other 
experimental cancer systems (Coussens 
and Werb, 2001). The findings also sug-
gested that γδ T cells may downregulate 
potentially tumor-promoting αβ T cells 
(see below). In summary, mouse stud-
ies have elucidated three different path-
ways by which γδ T cells may provide 
anticancer activities: (1) direct killing of 
transformed cells, (2) early IFN-γ pro-
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Figure 1. Immunosurveillance by γδ T cells in 
murine skin. According to this model, γδ T cells 
would recognize damaged keratinocytes (KCs) 
as those cells displaying the (yet unidentified) 
TCR ligand as well as ligands for NKG2D (for 
example, retinoic acid early-1 (Rae-1)). Such 
cells can be rapidly eliminated via secretion 
of granzymes and perforin. Concurrently, γδ T 
cells may promote 'microscopic wound healing' 
through the release of fibroblast growth factor-VII 
(FGF-VII; keratinocyte growth factor-1) and IGF-1 
(Sharp et al., 2005), stimulating lateral healthy 
keratinocytes to proliferate and fill in the voids. 
The secretion of anti-inflammatory compounds, 
as has been described for the lymphoid form 
of thymosin-β4 (L-Tβ4) (Girardi et al., 2003a), 
would also protect the epidermal barrier from the 
damaging effects of oxidative mediators released 
by neutrophils. Furthermore, the local secretion 
of IFN-γ by γδ T cells (Gao et al., 2003) would 
enhance the antimicrobial, antitumor, and other 
functional activities of natural killer (NK) and αβ 
T cells, thus maintaining epidermal integrity.
M Girardi.
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duction, and (3) a critical immunoregu-
latory mechanism. Thus, the antitumor 
role attributable to γδ T cells in the skin 
may be viewed as a component of a 
larger function of immunosurveillance 
and protection of the epidermal barrier 
(Figure 1).
T Regulatory Function by Dendritic 
Epidermal T Cells and Other γδ T Cells
The observation that γδ T cells express 
certain chemokines and other regulatory 
molecules characteristic of T regulatory 
cells is consistent with the findings that 
immune responses to several pathogens 
(for example, intestinal Eimeria, Listeria 
monocytogenes, Mycobacterium tuber-
culosis, and Klebsiella) are not appro-
priately regulated in γδ-deficient mice 
(Roberts et al., 1996; Mombaerts et al., 
1993; Mukasa et al., 1998; D’Souza 
et al., 1997). TCRδ–/– mice have also 
shown accelerated immune responses 
in non-infectious settings, most notably 
the MRL/lpr model of lupus erythema-
tosus (Peng et al., 1996) and an experi-
mental model of epidermal autoimmu-
nity mediated by αβ T cells (Shiohara 
et al., 1996). Strikingly, in the absence 
of γδ T cells, certain strains of mice 
will develop a spontaneous, αβ T cell-
dependent dermatitis, as well as aug-
mented responses to contact allergens 
and irritants (Girardi et al., 2002). The 
selective repopulation of TCRδ–/– mice 
with Vγ5+ DETCs by neonatal trans-
fer with fetal thymic DETC precursors 
abrogates the augmented dermatitis, 
thus demonstrating that the resident 
γδ T cells provide a local T regulatory 
function. Additionally, these findings 
raise the possibility that IELs might 
exhibit a T regulatory function for sys-
temic responses in other epithelial sites, 
including the intestine. This would be 
consistent with reports that IEL deficien-
cies are associated with human inflam-
matory bowel disease pathologies (Van 
Damme et al., 2001).
The mechanisms by which IELs may 
downregulate inflammatory responses 
in epithelia are beginning to be elu-
cidated (Pennington et al., 2005). For 
example, γδ+ IELs and DETCs express 
high levels of thymosin-β4 (Girardi 
et al., 2003a). Thymosin-β4 is found 
within all cells, but, consistent with its 
function in actin sequestration, the oxi-
dized form is a potent anti-inflamma-
tory agent (Young et al., 1999). 
Moreover, activated γδ+ T cells express 
high levels of an alternate spliced ver-
sion known as lymphoid thymosin-β4. 
Consistent with the observation that 
lymphoid thymosin-β4 contains an 
extra methionine that is readily oxi-
dized, this splice variant was shown in 
vivo to be particularly anti-inflamma-
tory in the skin (Girardi et al., 2003a). 
Nevertheless, a range of other possible 
activities may be operative, including 
expression of Fas ligand by γδ T cells, 
induction of Fas ligand on keratino-
cytes and secretion of cytokines such as 
transforming growth factor-β and IFN-γ 
(reviewed in Pennington et al., 2005).
γδ T Cells in Human Disease
The study of γδ T cells in mice has 
increased our understanding of these 
cells in the human, including their 
propensity for epithelial surfaces and 
their multidimensional immune effects. 
The absence of a precise phenotypic 
DETC homologue in human skin sug-
gests that functional equivalents must 
be operative. Whether these are pro-
vided by human dermal γδ T cells, infil-
trating peripheral γδ T cells, αβ T cells, 
and/or NK cells is being explored. 
Nevertheless, studies of the ligand sys-
tems used by murine γδ T cells, and the 
exploration of their parallel activities 
mediated by human γδ T cells as well 
as other lymphoid populations, are 
likely to continue to provide insight 
into immunosurveillance and immune 
regulation in human disease.
As discussed above, DETCs consti-
tutively express NKG2D, which recog-
nizes the MHC-Ib molecules Rae-1 and 
H60 that are induced by skin chemical 
carcinogens. Human NKG2D+ cells 
similarly recognize stress-induced 
MICA and MICB on a myriad of solid 
tumors (Pardoll, 2001). The importance 
of NKG2D and its ligands in tumor rec-
ognition and elimination is increasingly 
being recognized. For example, the 
avoidance of recognition by NKG2D+ 
cells has been elucidated as a mecha-
nism of tumor-driven immune evasion 
(Groh et al., 2002). Hence, it is crucial 
to clarify in humans which NKG2D+ 
cells actively mount an antitumor 
response, and to investigate potential 
means by which tumors may evade 
this attack (Oppenheim et al., 2005). 
Correspondingly, one major issue yet 
to be fully clarified in mouse γδ T-cell 
biology is the nature of the TCR ligands 
of DETCs and other γδ IELs, which rep-
resent a putative set of epithelium-spe-
cific danger signals. Once these TCR 
ligands are identified, the role of these 
molecules in epithelial homeostasis, 
tumor immunosurveillance, and regu-
lation of inflammatory responses might 
be elucidated experimentally and corre-
lated to human disease, in which novel 
therapeutic inroads may be made.
Furthermore, important strides con-
tinue to be made to explore the poten-
tial utility of human γδ T-cell subsets in 
immunotherapy protocols. Dendritic 
cell-based strategies, for example, target 
the adaptive immune system, providing 
peptide-antigen presentation and co-
stimulatory molecules that may induce 
antigen-specific antitumor immunity. 
However, this may lead to editing of 
the tumor population with selection of 
those tumor cells that have altered their 
expression of tumor antigens, antigen-
processing machinery, or MHC-present-
ing molecules (Dunn et al., 2004). Thus, 
complementary or integrative strategies 
are necessary. The phosphoantigen-
mediated stimulation and expansion 
of Vγ9Vδ2 peripheral T cells represents 
a source of autologous cells with the 
capacity to kill a variety of tumor cells 
independently of MHC presentation 
of peptide antigen (Morita et al., 2001; 
Bonneville and Fournie, 2005).
As mentioned previously, γδ T 
cells have features of both innate and 
adaptive immunity and may serve 
critical roles in bridging these types 
of responses. The recent identification 
of the capacity of Vγ9Vδ2+ T cells to 
function as APCs (Brandes et al., 2005) 
adds yet another layer of complexity to 
our understanding of γδ T-cell biology. 
Brandes and colleagues demonstrated 
that, like dendritic cells, Vγ9Vδ2+ T 
cells can express co-stimulatory mole-
cules and present conventional peptide 
antigens for the primary stimulation of 
CD4+ and CD8+ αβ T-cell responses. 
Hence, Vγ9Vδ2+ T cells may provide 
the ultimate link of innate and adap-
tive immunity by rapid expansion and 
secretion of cytokines (for example, 
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through recognition of isopentenyl 
pyrophosphate, IPP, and (E)-4-hydroxy-
3-methylbut-2-enyl diphosphate, MHB-
PP) within hours of any encounter with 
pathogenic organisms, and by process-
ing and presentation of foreign peptide 
to prime antigen-specific αβ T cells and 
coordinate a dual, innate and adaptive, 
immune response. As a potential ave-
nue of γδ T-cell immunotherapy, it may 
ultimately prove possible to use periph-
eral γδ T cells in antitumor protocols 
in which such cells are activated and 
exposed to tumor antigen and thus may 
serve a dual role of stimulating both γδ 
T cell-directed antitumor activity and 
tumor antigen-specific CD4 and CD8 
αβ T-cell responses.
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